InflaRx N.V. Announces Share Capital Amendment

TipRanksApr 26 05:31

InflaRx N.V. Announces 2024 AGM Details

TipRanksApr 5 04:58

Investor Optimism for InflaRx's INF904: Assessing Potential in CSU and HS Markets

TipRanksMar 25 09:25

LifeSci Capital Reaffirms Their Hold Rating on InflaRx (IFRX)

TipRanksMar 23 03:05

HC Wainwright & Co. Reiterates Buy on InflaRx, Maintains $8 Price Target

HC Wainwright & Co. analyst Edward White reiterates InflaRx with a Buy and maintains $8 price target.

Analyst UpgradesMar 22 20:22

Buy Rating Justified for InflaRx Despite Earnings Miss: Financial Stability and INF904's Market Potential

TipRanksMar 22 18:16